MJ DAILY EUROPE

United Kingdom-based GW Pharmaceuticals posted higher revenue in the quarter ended Sept. 30, largely driven by sales of its cannabidiol medicine Epidiolex in the United States. GW’s total revenue for the third quarter reached $137.1 million, about 16% more than the previous quarter’s $121.3 million. U.S. Epidiolex sales accounted for 87% of the company’s overall […] Epidiolex maker GW reports record quarterly revenue of $137 million is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Excerpt only …
READ MORE BELOW
Source : Epidiolex maker GW reports record quarterly revenue of 7 million

reposted by Cannabis News World